222404-25-3

Basic information

• Product Name: 4-Thiazolidinecarboxylic acid, 2-(4-methoxyphenyl)-, (4R)-
• Synonyms: (R)-2-(4-METHOXY-PHENYL)-THIAZOLIDINE-4-CARBOXYLIC ACID;4-Thiazolidinecarboxylic acid, 2-(4-methoxyphenyl)-, (4R)-
• CAS NO: 222404-25-3
• Molecular Formula: C₁₁H₁₃NO₃S
• Molecular Weight: 239.29
• Mol File: 222404-25-3.mol
• Article Data: 21

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 4-Thiazolidinecarboxylic acid, 2-(4-methoxyphenyl)-, (4R)-(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Thiazolidinecarboxylic acid, 2-(4-methoxyphenyl)-, (4R)-(222404-25-3)
• EPA Substance Registry System: 4-Thiazolidinecarboxylic acid, 2-(4-methoxyphenyl)-, (4R)-(222404-25-3)

Safety Data

• Hazardous Substances Data: 222404-25-3(Hazardous Substances Data)

Upstream product

• 32443-99-5 D-cysteine hydrochloride 
• 123-11-5 4-methoxy-benzaldehyde 
• 52-89-1 l-cysteine hydrochloride 
• 52-90-4 L-Cysteine 

Downstream Products

• 637032-07-6 (4R)-3-(tert-butoxycarbonyl)-2-(4-methoxyphenyl)thiazolidine-4-carboxylic acid 
• 1148154-79-3 (2R,4R)-3-(tert-butoxycarbonyl)-2-(4-methoxyphenyl)-thiazolidine-4-carboxylic acid 
• 78979-46-1 (4R) ethyl 2-(4-methoxyphenyl)thiazolidine-4-carboxylate 
• 1609535-71-8 (3R)-6,7-bis(hydroxymethyl)-3-(4-methoxyphenyl)-5-methyl-1H,3H-pyrrolo[1,2-c]thiazole 
• 1071689-48-9 dimethyl (3R)-3-(4-methoxyphenyl)-5-methyl-1H,3H-pyrrolo[1,2-c]thiazole-6,7-dicarboxylate 
• 65776-11-6 (R)-3-mercapto-2-(4-methoxy-benzylamino)-propionic acid 
• 69570-41-8 (R)-3-((S)-3-Mercapto-2-methyl-propionyl)-2-(4-methoxy-phenyl)-thiazolidine-4-carboxylic acid 
• 72678-38-7 (R)-3-(3-Mercapto-propionyl)-2-(4-methoxy-phenyl)-thiazolidine-4-carboxylic acid 
• 18942-46-6 N-(tert-butyloxycarbonyl)-S-(4-methoxybenzyl)cysteine 
• 350035-37-9 (R)-3-[(R)-3-Hydroxy-2-(4-methoxy-benzylamino)-propyldisulfanyl]-2-(4-methoxy-benzylamino)-propan-1-ol 
• 2544-31-2 S-(4-methoxybenzyl)-L-cysteine 
• 72678-39-8 (R)-3-((S)-3-Benzoylsulfanyl-2-methyl-propionyl)-2-(4-methoxy-phenyl)-thiazolidine-4-carboxylic acid 
• 110078-94-9 (2S,4R)-3-Acetyl-2-(4-methoxy-phenyl)-thiazolidine-4-carboxylic acid 
• 110078-83-6 (2R,4R)-3-Acetyl-2-(4-methoxy-phenyl)-thiazolidine-4-carboxylic acid 

Relevant articles and documents

Discovery of cysteine and its derivatives as novel antiviral and antifungal agents

Based on the structure of the natural product cysteine, a series of thiazolidine-4-carboxylic acids were designed and synthesized. All target compounds bearing thiazolidine-4-carboxylic acid were characterized by1 H-NMR,13 C-NMR, and

Purple acid phosphatase inhibitors as leads for osteoporosis chemotherapeutics

Purple acid phosphatases (PAPs) are metalloenzymes that catalyse the hydrolysis of phosphate esters under acidic conditions. Their active site contains a Fe(III)Fe(II) metal centre in mammals and a Fe(III)Zn(II) or Fe(III)Mn(II) metal centre in plants. In humans, elevated PAP levels in serum strongly correlate with the progression of osteoporosis and metabolic bone malignancies, which make PAP a target suitable for the development of chemotherapeutics to combat bone ailments. Due to difficulties in obtaining the human enzyme, the corresponding enzymes from red kidney bean and pig have been used previously to develop specific PAP inhibitors. Here, existing lead compounds were further elaborated to create a series of inhibitors with Ki values as low as ～30 μM. The inhibition constants of these compounds were of comparable magnitude for pig and red kidney bean PAPs, indicating that relevant binding interactions are conserved. The crystal structure of red kidney bean PAP in complex with the most potent inhibitor in this series, compound 4f, was solved to 2.40 ? resolution. This inhibitor coordinates directly to the binuclear metal centre in the active site as expected based on its competitive mode of inhibition. Docking simulations predict that this compound binds to human PAP in a similar mode. This study presents the first example of a PAP structure in complex with an inhibitor that is of relevance to the development of anti-osteoporotic chemotherapeutics.

Synthesis, characterization and antibacterial activities of N-tert-butoxycarbonyl-thiazolidine carboxylic acid

A possible mechanism of dynamic kinetic resolution by the formation of N-tert-butoxycarbonyl-thiazolidine carboxylic acid was proposed and validated by a quantitative density functional theoretical calculation according to Curtin-Hammett principle. Such a